TWEAK as a target for therapy in systemic lupus erythematosus

Author： Leng Rui-Xue   Pan Hai-Feng   Qin Wei-Zi   Wang Chao   Chen Li-Li   Tao Jin-Hui   Ye Dong-Qing  

Publisher： Springer Publishing Company

ISSN： 0301-4851

Source： Molecular Biology Reports, Vol.38, Iss.1, 2011-01, pp. : 587-592

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin-21 as a potential therapeutic target for systemic lupus erythematosus

By Li Jing   Pan Hai-Feng   Cen Han   Tian Jing   Ma Yan   Tao Jin-Hui   Ye Dong-Qing  

Molecular Biology Reports, Vol. 38, Iss. 6, 2011-08 ,pp. : 4077-4081

Springer Publishing Company

Access to resources Recommend Favorite

Potential for anti-DNA immunoglobulin peptide therapy in systemic lupus erythematosus

By Iikuni Noriko   H Hahn Bevra   La Cava Antonio  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 2, 2009-02 ,pp. : 201-206

Informa Healthcare

Access to resources Recommend Favorite

Abatacept for systemic lupus erythematosus: the outlook

By Mok Chi Chiu  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 12, 2012-12 ,pp. : 1559-1561

Informa Healthcare

Access to resources Recommend Favorite

Belimumab for the management of systemic lupus erythematosus

By Lutalo Pamela M K   D'Cruz David P  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 7, 2012-07 ,pp. : 957-963

Informa Healthcare

Access to resources Recommend Favorite

Allogenic bone-marrow-derived mesenchymal stem cells transplantation as a novel therapy for systemic lupus erythematosus

By Zhang Huayong   Zeng Xiaofeng   Sun Lingyun  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 5, 2010-05 ,pp. : 701-709

Informa Healthcare

Access to resources Recommend Favorite